A real-world propensity analysis of the impact of GLP-1 receptor agonists on cancer therapy-related cardiac dysfunction
Abstract Background Heart damage caused by cancer treatment can lead to heart failure, hospital admission, and death. Medications known as glucagon-like peptide-1 receptor agonists are widely used to treat type 2 diabetes with cardioprotective potentials. Whether these medications can reduce heart d...
Збережено в:
| Автори: | , , , , , |
|---|---|
| Формат: | Artigo |
| Мова: | Inglês |
| Опубліковано: |
Nature Portfolio
2026-04-01
|
| Серія: | Communications Medicine |
| Онлайн доступ: | https://doi.org/10.1038/s43856-026-01618-2 |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|